Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

NCT00953849 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

FED

Sponsor class

Conditions

Mouth Neoplasms

Interventions

DRUG: Celecoxib
DRUG: Calcitriol
DRUG: Celecoxib plus Calcitriol

Sponsor

VA Office of Research and Development